These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21284268)

  • 1. Do race and ethnicity predict survival in metastatic non-small cell lung cancer?
    Berz D; Faricy-Anderson KE; Weitzen S; Birnbaum A; Strauss G
    Med Health R I; 2010 Oct; 93(10):299-302. PubMed ID: 21284268
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of age on survival of clinical stage I non-small-cell lung cancer.
    Sigel K; Bonomi M; Packer S; Wisnivesky J
    Ann Surg Oncol; 2009 Jul; 16(7):1912-7. PubMed ID: 19408051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors predicting poor survival after resection of stage IA non-small cell lung cancer.
    Chang MY; Mentzer SJ; Colson YL; Linden PA; Jaklitsch MT; Lipsitz SR; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2007 Oct; 134(4):850-6. PubMed ID: 17903494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in colorectal cancer incidence rates by age, race/ethnicity, and indices of access to medical care, 1995–2004 (United States).
    Hao Y; Jemal A; Zhang X; Ward EM
    Cancer Causes Control; 2009 Dec; 20(10):1855-63. PubMed ID: 19543799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status.
    Ou SH; Zell JA; Ziogas A; Anton-Culver H
    Cancer; 2008 May; 112(9):2011-20. PubMed ID: 18361399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
    Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
    Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subcategorization of resectable non-small cell lung cancer involving neighboring structures.
    Sakakura N; Mori S; Ishiguro F; Fukui T; Hatooka S; Shinoda M; Yokoi K; Mitsudomi T
    Ann Thorac Surg; 2008 Oct; 86(4):1076-83; discussion 1083. PubMed ID: 18805135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extent of lymphadenectomy and outcome for patients with stage I nonsmall cell lung cancer.
    Varlotto JM; Recht A; Nikolov M; Flickinger JC; Decamp MM
    Cancer; 2009 Feb; 115(4):851-8. PubMed ID: 19140203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in breast cancer hormone receptor status and histology by race and ethnicity among women 50 years of age and older.
    Li CI; Malone KE; Daling JR
    Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):601-7. PubMed ID: 12101106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Survival after surgical resection for stage IV non-small cell lung cancer].
    Kawai H; Matsuzaki I; Ogawa J
    Kyobu Geka; 2006 Jan; 59(1):21-3. PubMed ID: 16440680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of solitary extracranial metastases from non-small cell lung cancer.
    Luketich JD; Martini N; Ginsberg RJ; Rigberg D; Burt ME
    Ann Thorac Surg; 1995 Dec; 60(6):1609-11. PubMed ID: 8787451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy.
    Varlotto JM; Flickinger JC; Recht A; Nikolov MC; DeCamp MM
    Cancer; 2008 Apr; 112(7):1547-54. PubMed ID: 18260087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of sex in non-small cell lung cancer.
    Wheatley-Price P; Blackhall F; Thatcher N
    Onkologie; 2009 Oct; 32(10):547-8. PubMed ID: 19816068
    [No Abstract]   [Full Text] [Related]  

  • 15. [Non-small cell lung cancer: surgical trends as a function of age].
    Riquet M; Medioni J; Manac'h D; Dujon A; Souilamas R; Le Pimpec Barthes F; Hubsch JP
    Rev Mal Respir; 2001 Apr; 18(2):173-84. PubMed ID: 11424713
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misclassification of race/ethnicity in a population-based cancer registry (United States).
    Gomez SL; Glaser SL
    Cancer Causes Control; 2006 Aug; 17(6):771-81. PubMed ID: 16783605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic factors in unresectable lung cancer].
    Urata A
    Gan To Kagaku Ryoho; 1988 Jul; 15(7):2035-42. PubMed ID: 2840034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.
    Sakao Y; Miyamoto H; Yamazaki A; Oh T; Fukai R; Shiomi K; Saito Y
    Ann Thorac Surg; 2006 Jan; 81(1):292-7. PubMed ID: 16368383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A prognostic analysis of N0-1M0 intralobar metastatic non-small cell lung cancer].
    Yang HX; Hou X; Lin P; Rong TH; Yang H; Fu JH
    Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2486-9. PubMed ID: 20137436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated mediastinal skip metastasis in lung cancer: is it real N2 disease?
    Puma F
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):235. PubMed ID: 15632859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.